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Objectives. Lipoprotein(a) consists of an LDL-particle
attached to apolipoprotein(a), which is made by the
liver. Diterpenes present in boiled coffee raise serum
levels of LDL cholesterol and of the liver enzyme
alanine aminotransferase in man. We investigated
the association between intake of boiled coffee and
serum levels of lipoprotein(a).
Design, setting and subjects. Healthy Norwegians
40–42 years of age, who habitually consumed five or
more cups of boiled coffee per day (n¯150) were
compared with matched filter coffee consumers
(n¯159) in a cross-sectional study, as part of the
Norwegian National Health Screening in 1992.
Introduction
Lipoprotein(a) [Lp(a)] consists of a large glycoprotein,
apolipoprotein(a), attached to an LDL molecule [1].
A high serum Lp(a) level is a risk factor for developing
coronary atherosclerosis and other vascular diseases
[1–5]. Lp(a) levels are largely under genetic control
[6], and are unaffected by many factors that modulate
LDL-cholesterol levels [1, 7], including diet [8]. An
exception is formed by dietary trans fatty acids,
which raise serum Lp(a) levels [9, 10].
Consumption of unfiltered, boiled coffee is
associated with raised serum cholesterol levels in
humans in both intervention trials [11–13] and
epidemiological studies [14–17]. Recently, it was
shown that the diterpenes cafestol and kahweol are
Results. The median lipoprotein(a) level was 13.0 mg
dL−" (10th and 90th percentile : 2.5 and 75.0 mg
dL−", respectively) on boiled and 7.9 mg dL−" (10th
and 90th percentile : 1.9 and 62.5 mg dL−", respect-
ively) on filter coffee (P¯0.048). Means³SE were
25.8³2.4 mg dL−" and 19.6³2.0 mg dL−", respec-
tively (P¯0.04). Although not statistically signi-
ficant, subjects consuming nine or more cups of
coffee per day had higher lipoprotein(a) levels than
those drinking five to eight cups per day in both
coffee groups.
Conclusion. Chronic consumers of unfiltered, boiled
coffee have higher serum levels of lipoprotein(a) than
filter coffee drinkers.
Keywords : boiled coffee, cross-sectional study,
lipoprotein(a), Norwegians.
responsible for the hyperlipidaemic effects of boiled
coffee [18, 19]. Scandinavian boiled coffee provides
3–4 mg of each diterpene per cup, whereas paper-
filtered coffee contains less than 0.1 mg of each
diterpene per cup [20].
The liver appears to be the target organ of coffee
diterpenes, as cafestol and kahweol elevate the serum
activity of alanine aminotransferase [19, 21] and
reduce that of c-glutamyltransferase [19, 22]. The
liver is also the main source of apolipoprotein(a)
[23], and the serum level of Lp(a) is largely de-
termined by the rate of Lp(a) production [24].
Whether ingestion of coffee diterpenes with boiled
coffee results in altered serum levels of Lp(a) is as yet
unknown.
We compared serum Lp(a) levels in healthy
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Norwegians consuming unfiltered boiled coffee with
those in matched filter-coffee drinkers.
Materials and methods
Subjects
Subjects were recruited as part of the Norwegian
National Health Screening in 1992, a population-
based study in southern Norway [17]. Persons aged
40–42 years attending the screening were asked to
fill out a questionnaire concerning their coffee usage.
Those who reported drinking five or more cups of
either boiled or filter coffee per day received an oral
explanation about the purpose of our study. The
questionnaire did not provide information on dur-
ation and history of coffee intake. Subjects were
considered eligible if they were healthy, did not take
any medication known to affect liver enzymes or
serum lipids, and did not consume more than three
alcohol-containing beverages per day. Those who
were willing to participate gave their written
informed consent. Prior approval for the study was
obtained from the appropriate Committee on Human
Ethics.
Blood sampling and assays
Non-fasting blood was obtained by venepuncture,
allowed to clot, and centrifuged. Sera were randomly
coded, shipped to Wageningen, and stored at
®80 °C. Lp(a) was assayed blindly within 12 months
with an enzyme-linked immunosorbent assay
(Immunozym Lp(a), Immuno GMBH, Heidelberg,
Germany). The lower limit of detection of Lp(a) was
1 mg dL−", which according to the manufacturer is
higher than the maximum cross-reactivity of the
Lp(a)-antibodies with plasminogen and apolipo-
protein B. For each subject, Lp(a) was analysed in
duplicate in separate runs. The intra- and interassay
coefficients of variation for a control pool (target
14–21 mg dL−") were 14.8 and 9.6%, respectively,
over a period of 3 months. Serum lipids and serum
activities of liver enzymes were assayed as described
[12].
Statistical analyses
Unpaired, two-sided t-tests were used to compare the
means of serum variables between the two groups.
As the distributions of Lp(a) levels were positively
skewed, we also compared the two groups with
Mann–Whitney U tests.
Results
Consumers of boiled (n¯150) and filter coffee
(n¯159) were well matched with regard to sex, age,
body mass index, use of medicines, smoking habits
and alcohol consumption (Table 1). The use of boiled
coffee was associated with higher serum levels of
total cholesterol and lower serum activities of
c-glutamyltransferase, in agreement with earlier
findings [14–17, 25].
The median level of Lp(a) was 13.0 mg dL−" (range
0–130 mg dL−") among consumers of boiled coffee
and 7.9 mg dL−" (range 0–144 mg dL−") among
consumers of filter coffee (P¯0.048) (Fig. 1) ;
means³SE were 25.8³2.4 mg dL−" and 19.6³
2.0 mg dL−", respectively (P¯0.047).
The median Lp(a) levels were for men 14.1 mg
dL−" for boiled and 7.8 mg dL−" for filter coffee, and
for women 10.7 mg dL−" for boiled and 8.3 mg dL−"
for filter coffee. The median Lp(a) level was 13.6 mg
dL−" in the subjects drinking more than nine cups of
boiled coffee per day, and 11.7 mg dL−" in those
drinking less than nine cups. For filter coffee, the
Table 1 Characteristics of 309 healthy Norwegians aged 40–42
years chronically drinking five or more cups of boiled or filter
coffee per daya
Filter coffee Boiled coffee
n¯159 n¯150
Number of men}women 88}71 79}71
Age (years) 41³1 41³1
Body Mass Index (kg m−#) 25³3 25³4
Women taking contraceptive steroids 2 2
Coffee consumption
Five to eight cups per day 133 117
Nine or more cups per day 26 33
Smokers 89 87
Alcohol users 146 135
Medication usersb 20 21
Total cholesterol (mmol L−") 5.67³1.05 5.98³1.08c
Triglycerides (mmol L−") 1.92³1.24 2.14³1.55
Alanine aminotransferase (U L−") 19³10 20³10
Aspartate aminotransferase (U L−") 22³7 22³7
c-Glutamyltransferase (U L−") 26³24 20³17c
aValues are numbers, or means³SD.
bAny medications used in the month previous to the screening.
None of the subjects used medicines on a daily basis.
c Significantly different from filter coffee group: P!0.05.
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Fig. 1 Serum lipoprotein(a) levels among 309 healthy
Norwegians aged 40–42 years, chronically consuming five or
more cups of boiled (n¯150) or filter coffee (n¯159) per day.
Values represent the serum Lp(a) level of the 15th, 30th, 45th
etc. consumer of boiled coffee, and the 16th, 32nd, 48th, etc.
consumer of filter coffee when subjects were ranked according
to lipoprotein (a) level within coffee usage groups.
corresponding values were 8.0 mg dL−", and 6.9 mg
dL−", respectively (all differences P"0.05).
Discussion
We found that the median level of serum Lp(a) in
Norwegians habitually consuming unfiltered, boiled
coffee was significantly higher than in their peers
drinking filter coffee. Our data also suggests that the
elevation of Lp(a) may depend on the amount of
coffee consumed, and that the effect of boiled coffee is
stronger in men than in women. These results did
not reach statistical significance, however, which
may be attributable to reduced power due to limited
sample sizes.
The insensitivity of Lp(a) levels to environmental
influences [7, 8] renders it unlikely that our finding
was biased. In addition, the two groups were well
matched with respect to age, sex, body mass index,
smoking habits, and alcohol use. The use of drugs or
contraceptive pills during the previous month in the
two groups was infrequent and similarly distributed
(Table 1). Dietary factors that influence Lp(a) levels
are limited to trans fatty acids [9, 10] and possibly
fish oils [8]. It is unlikely, however, that consumers
of boiled and filter coffee differed enough in their
intake of fatty acids to explain the effect seen here.
The Lp(a) particle contains apolipoprotein(a)
[apo(a)], which is remarkably polymorphic [26].
Serum Lp(a) levels correlate inversely with the
molecular weight of the apo(a) isoform and the size
of the corresponding gene [27]. We have no in-
formation on apo(a) phenotype distribution of the
two groups. Although all subjects were living in
southern Norway, more people consuming boiled
coffee may have descended from ancestors that
originated from northern Norway—where consump-
tion of boiled coffee is more common [17]. Therefore,
confounding by genetic differences cannot be fully
excluded.
The higher level of Lp(a) among boiled-coffee
consumers was an unexpected finding. In two short-
term controlled trials with a large number of Dutch
volunteers, coffee oil rich in diterpenes significantly
lowered serum Lp(a) (Urgert et al., 1996, unpublished
observations). In the present study, serum levels of
cholesterol were higher in the boiled-coffee group,
and c-glutamyltransferase activities were lower,
which is consistent with both epidemiological
[14–17, 25] and experimental studies [19]. These
variables, as well as the Lp(a) concentration of each
subject were determined blindly in the same set of
serum aliquots. In addition, all sera of subjects
consuming boiled or filter coffee had been stored
under the same conditions, and analysed for Lp(a) in
random order, except for one analysis run which
after breaking of the code turned out to have
comprised sera of 36 boiled-coffee drinkers and no
filter-coffee drinkers, and one run that had contained
sera of 42 filter-coffee drinkers and only nine boiled-
coffee drinkers. However, the median level of Lp(a)
in the first run was 11.5 mg dL−" (n¯36) against
13.0 mg dL−" for the entire boiled-coffee group
(n¯150), and in the second run 8.6 mg dL−"
(n¯42) against 7.9 mg dL−" for the entire filter-
coffee group (n¯159). Therefore, if any systematic
bias was introduced at this stage, it should have
weakened the association between coffee type and
Lp(a) levels instead of having strengthened it.
Therefore, there seems to be a discrepancy between
effects on Lp(a) levels with short-term and chronic
intake of coffee diterpenes. In short-term trials, it
was observed that coffee diterpenes increased serum
activities of alanine aminotransferase [19, 22]. This
suggests that the liver is the target organ for coffee
diterpenes. Disturbed hepatocyte integrity may re-
duce circulating Lp(a) levels, as seen in patients with
biliary cirrhosis or other liver disease [28, 29]. In the
present study, however, the boiled-coffee drinkers
had no elevated serum activities of alanine amino-
transferase ([19], see also Table 1). It is therefore
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possible that the liver adapts to the effects of cafestol
and kahweol with chronic consumption of boiled
coffee. Therefore, intervention trials of longer dur-
ation are needed to reveal the time course of the
effect of coffee diterpenes on serum Lp(a).
Tverdal et al. [30] found an effect of boiled-coffee
consumption on mortality from coronary heart
disease, over and above its effect on serum chol-
esterol. Higher serum levels of Lp(a) in those drinking
boiled coffee, as observed in this study, might partly
account for this additional risk.
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